Source:http://linkedlifedata.com/resource/pubmed/id/16965699
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-9-12
|
pubmed:abstractText |
Detecting beta-lactamase-mediated carbapenem resistance among Klebsiella pneumoniae isolates and other Enterobacteriaceae is an emerging problem. In this study, 15 blaKPC-positive Klebsiella pneumoniae that showed discrepant results for imipenem and meropenem from 4 New York City hospitals were characterized by isoelectric focusing; broth microdilution (BMD); disk diffusion (DD); and MicroScan, Phoenix, Sensititre, VITEK, and VITEK 2 automated systems. All 15 isolates were either intermediate or resistant to imipenem and meropenem by BMD; 1 was susceptible to imipenem by DD. MicroScan and Phoenix reported 1 (6.7%) and 2 (13.3%) isolates, respectively, as imipenem susceptible. VITEK and VITEK 2 reported 10 (67%) and 5 (33%) isolates, respectively, as imipenem susceptible. By Sensititre, 13 (87%) isolates were susceptible to imipenem, and 12 (80%) were susceptible to meropenem. The VITEK 2 Advanced Expert System changed 2 imipenem MIC results from >16 ?g/mL to <2 ?g/mL but kept the interpretation as resistant. The recognition of carbapenem-resistant K. pneumoniae continues to challenge automated susceptibility systems.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carbapenems,
http://linkedlifedata.com/resource/pubmed/chemical/Imipenem,
http://linkedlifedata.com/resource/pubmed/chemical/Thienamycins,
http://linkedlifedata.com/resource/pubmed/chemical/meropenem
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1080-6040
|
pubmed:author |
pubmed-author:BiddleJames WJW,
pubmed-author:CareyRoberta BRB,
pubmed-author:HannaBruceB,
pubmed-author:KalsiRajinder KRK,
pubmed-author:LonswayDavidD,
pubmed-author:McGowanJohn EJEJr,
pubmed-author:RasheedJ KamileJK,
pubmed-author:StockerSheilaS,
pubmed-author:TenoverFred CFC,
pubmed-author:WilliamsPortia PPP
|
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1209-13
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16965699-Anti-Bacterial Agents,
pubmed-meshheading:16965699-Automation,
pubmed-meshheading:16965699-Carbapenems,
pubmed-meshheading:16965699-Drug Resistance, Bacterial,
pubmed-meshheading:16965699-Humans,
pubmed-meshheading:16965699-Imipenem,
pubmed-meshheading:16965699-Klebsiella pneumoniae,
pubmed-meshheading:16965699-Microbial Sensitivity Tests,
pubmed-meshheading:16965699-Reference Standards,
pubmed-meshheading:16965699-Thienamycins
|
pubmed:year |
2006
|
pubmed:articleTitle |
Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.
|
pubmed:affiliation |
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA. fnt1@cdc.gov
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|